COVID-19 Pediatric Dermatology - 21/09/21

Doi : 10.1016/j.det.2021.05.012

Holly Neale, BS ^a,^b, Elena B. Hawryluk, MD, PhD ^a,^c,^d,^⁎
^a Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA
^b University of Massachusetts Medical School, Worcester, MA, USA
^c Harvard Medical School, Boston, MA, USA
^d Boston Children’s Hospital, Boston, MA, USA

^∗Corresponding author. Department of Dermatology, Massachusetts General Hospital, Boston, MA.Department of DermatologyMassachusetts General HospitalBostonMA

connectez-vous ou créez un compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Children are a unique subset of patients in relation to the COVID-19 pandemic, often presenting asymptomatically, mildly, or atypically. Manifestations of the skin may be a primary (or the only) presenting sign. Recognizing cutaneous manifestations of COVID-19 in the pediatric population is important to guiding precautions, testing, and management for patients and close contacts. Whereas some dermatologic signs in children overlap with those in adults, other skin findings are reported with higher frequency in children and may be clues to multisystemic sequelae. This article describes presentation, pathophysiologic theories, and management strategies for cutaneous manifestations of COVID-19 in children.

Le texte complet de cet article est disponible en PDF.

Keywords : MIS-C, Pediatric dermatology, COVID-19 children, Perniosis, Pernio-like lesions